financetom
NRC
financetom
/
Healthcare
/
NRC
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
National Research CorporationNRC
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.

Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty.

The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools.

In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools.

Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership.

National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Latest News >
UK ousts antitrust boss for failing to back growth agenda
UK ousts antitrust boss for failing to back growth agenda
Jan 22, 2025
* CMA chair to be replaced by former Amazon boss * Government wants regulators to focus on growth (Adds details throughout, reaction) By Paul Sandle DAVOS, Switzerland, Jan 22 (Reuters) - Britain forced out the chair of its antitrust regulator after he failed to prioritise its growth agenda, replacing him with a former Amazon boss, in a signal the UK's...
Ripple vs. SEC Settlement Rumors Gain Momentum: Here’s Why
Ripple vs. SEC Settlement Rumors Gain Momentum: Here’s Why
Jan 22, 2025
TL;DR Speculation is rising that the SECs upcoming closed meeting under new Acting Chairman Mark Uyeda might address the Ripple lawsuit, but experts warn against expecting major developments. Despite Genslers exit, the Ripple-SEC legal battle continues, with disputes over XRPs classification and an ongoing appeal delaying resolution. Incoming Resolution or Just Another Speculation? The lawsuit between Ripple and the US...
Solana, Dogecoin Gain 6% Daily as Bitcoin Holds Steady at $105K (Market Watch)
Solana, Dogecoin Gain 6% Daily as Bitcoin Holds Steady at $105K (Market Watch)
Jan 22, 2025
After the recent enhanced volatility across the entire crypto market, bitcoins price has finally calmed and stands still at around $105,000. Many altcoins have recovered some ground following yesterdays declines, and the total market cap is close to $3.8 trillion. BTC Calms at $105K The primary cryptocurrency jumped past $100,000 at the end of the previous business week and went...
Analysis-Japan Inc will struggle to follow SoftBank's lead and go big with Trump
Analysis-Japan Inc will struggle to follow SoftBank's lead and go big with Trump
Jan 22, 2025
TOKYO (Reuters) - SoftBank CEO Masayoshi Son's plan to invest billions in AI in the United States shows one way to handle the new Trump administration: go big and deal with the details later. For a Japan Inc anxious about how to navigate the second term of President Donald Trump - and the threat of steep tariffs or other punitive...
Copyright 2023-2025 - www.financetom.com All Rights Reserved